Squarepoint Ops LLC Marker Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $20,422 - $38,672	-10,863 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.47 - $3.29 $28,510 - $63,809	-19,395 Reduced 64.1%	10,863 $24,000
Q4 2020 Feb 16, 2021	BUY	$1.36 - $1.75 $41,150 - $52,951	30,258 New	30,258 $44,000
Q2 2020 Aug 14, 2020	SELL	$1.69 - $2.79 $22,368 - $36,928	-13,236 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.59 - $3.35 $942 - $1,986	593 Added 4.69%	13,236 $25,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $33,883 - $61,318	12,643 New	12,643 $36,000
Q2 2019 Aug 14, 2019	SELL	$5.15 - $7.92 $116,184 - $178,675	-22,560 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.1 - $6.71 $115,055 - $151,377	22,560 New	22,560 $149,000

472K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $234M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.